JUN 12, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Clonazepam (Manufacturing (CMC))
U.S. Food and Drug Administration
FDA supplemental approval for manufacturing changes to clonazepam tablets; no clinical efficacy or safety data reported.
Reported
Approval date2026-06-12
Application typeANDA supplement (Manufacturing/CMC)
Approved strengths0.25 mg, 0.5 mg, 1 mg, 2 mg tablets